These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 7488094)

  • 1. Maxadilan binds to membrane fractions of brain tissue.
    Moro O; Tsomides TJ; Tajima M; Lerner EA
    Biochem Biophys Res Commun; 1995 Nov; 216(1):234-41. PubMed ID: 7488094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors for the vasodilator maxadilan are expressed on selected neural crest and smooth muscle-derived cells.
    Moro O; Tajima M; Lerner EA
    Insect Biochem Mol Biol; 1996 Dec; 26(10):1019-25. PubMed ID: 9035385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasorelaxant and second messenger effects of maxadilan.
    Grevelink SA; Osborne J; Loscalzo J; Lerner EA
    J Pharmacol Exp Ther; 1995 Jan; 272(1):33-7. PubMed ID: 7815348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis.
    Lerner EA; Ribeiro JM; Nelson RJ; Lerner MR
    J Biol Chem; 1991 Jun; 266(17):11234-6. PubMed ID: 2040631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maxadilan interacts with receptors for pituitary adenylyl cyclase activating peptide in human SH-SY5Y and SK-N-MC neuroblastoma cells.
    Eggenberger M; Born W; Zimmermann U; Lerner EA; Fischer JA; Muff R
    Neuropeptides; 1999 Apr; 33(2):107-14. PubMed ID: 10657479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor.
    Soares MB; Titus RG; Shoemaker CB; David JR; Bozza M
    J Immunol; 1998 Feb; 160(4):1811-6. PubMed ID: 9469441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilatory properties of recombinant maxadilan.
    Jackson TS; Lerner E; Weisbrod RM; Tajima M; Loscalzo J; Keaney JF
    Am J Physiol; 1996 Sep; 271(3 Pt 2):H924-30. PubMed ID: 8853326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary gland homogenates of Lutzomyia longipalpis and its vasodilatory peptide maxadilan cause plasma leakage via PAC1 receptor activation.
    Svensjö E; Saraiva EM; Bozza MT; Oliveira SM; Lerner EA; Scharfstein J
    J Vasc Res; 2009; 46(5):435-46. PubMed ID: 19176972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory properties of maxadilan, the vasodilator peptide from sand fly salivary gland extracts.
    Qureshi AA; Asahina A; Ohnuma M; Tajima M; Granstein RD; Lerner EA
    Am J Trop Med Hyg; 1996 Jun; 54(6):665-71. PubMed ID: 8686790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural characterization and location of disulphide linkages of a potent vasodilatory peptide, recombinant maxadilan, by a multiple mass spectrometric approach.
    Yoshida S; Takamatsu T; Denda S; Ohnuma M; Tajima M; Lerner EA; Kanda F
    Rapid Commun Mass Spectrom; 1996; 10(6):641-8. PubMed ID: 8624417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue and species variation in the vascular receptor binding of 3H-P1075, a potent KATP opener vasodilator.
    Higdon NR; Khan SA; Buchanan LV; Meisheri KD
    J Pharmacol Exp Ther; 1997 Jan; 280(1):255-60. PubMed ID: 8996204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of recombinant rat placental lactogen-I with extracellular domains of prolactin receptors from three species.
    Sakal E; Robertson MC; Chapnik-Cohen N; Tchelet A; Gertler A
    Recept Signal Transduct; 1996; 6(1):35-42. PubMed ID: 8933620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Gulf War Syndrome an autoimmune disorder of endogenous neuropeptides, exogenous sandfly maxadilan and molecular mimicry?
    Staines DR
    Med Hypotheses; 2004; 62(5):658-64. PubMed ID: 15082085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and distribution of prolactin releasing peptide (PrRP) binding sites in the rat--evidence for a novel binding site subtype in cardiac and skeletal muscle.
    Satoh F; Smith DM; Gardiner JV; Mahmoodi M; Murphy KG; Ghatei MA; Bloom SR
    Br J Pharmacol; 2000 Apr; 129(8):1787-93. PubMed ID: 10780987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central melatonin binding sites in rainbow trout (Onchorhynchus mykiss).
    Davies B; Hannah LT; Randall CF; Bromage N; Williams LM
    Gen Comp Endocrinol; 1994 Oct; 96(1):19-26. PubMed ID: 7843564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maxadilan. Cloning and functional expression of the gene encoding this potent vasodilator peptide.
    Lerner EA; Shoemaker CB
    J Biol Chem; 1992 Jan; 267(2):1062-6. PubMed ID: 1730635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex.
    Lanzaro GC; Lopes AH; Ribeiro JM; Shoemaker CB; Warburg A; Soares M; Titus RG
    Insect Mol Biol; 1999 May; 8(2):267-75. PubMed ID: 10380110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.